Tag: Metacrine

Equity Investing

Metacrine, Inc. (MTCR) stock falls around 49.87% in aftermarket – Here’s why?

Metacrine, Inc. (MTCR) experienced a decline of 49.87% in the aftermarket because the company released Interim Results for the MET642 Phase 2a Trial. However, the

Catching News are non-trivial topics and publications about how you make money and properly dispose of it. We tell about business and entrepreneurship, start-ups, success stories. We also specialize in economic news.

Tag: Metacrine

Metacrine, Inc. (MTCR) stock falls around 49.87% in aftermarket – Here’s why?

Popular Articles

NOVONIX (NVX) Stock Sees Significant Rise Ahead Of Company Update

Surge In Greenland Technologies (GTEC) Shares Signals Market Confidence

Soluna Holdings (SLNH) Soars On Charts After Unveiling Game-Changing Initiative

Important Links